Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia

被引:68
作者
Bays, Harold [1 ]
Abate, Nicola [2 ,3 ]
Chandalia, Manisha [4 ]
机构
[1] L MARC Res Ctr, Louisville, KY 40213 USA
[2] Ctr Human Nutr, Div Endocrinol & Metab & Clin Nutr, Internal Med, Dallas, TX USA
[3] Ctr Human Nutr, UT Southwestern Lipid & Heart Dis Risk Management, Dallas, TX USA
[4] Ctr Human Nutr, Internal Med, Div Endocrinol & Metab & Clin Nutr,Risk Managemen, UT Southwestern Lipid & Heart Dis Risk Management, Dallas, TX USA
关键词
adipose autodysharmonia; adiposopathy diabetes; Food and Drug Administration; hypertension; obesity metabolic cycle; metabolic syndrome; obesity; regulatory;
D O I
10.1517/14796678.1.1.39
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adiposopathy is defined as pathological adipose tissue function that may be promoted and exacerbated by fat accumulation (adiposity) and sedentary lifestyle in genetically susceptible patients. Adiposopathy is a root cause of some of the most common metabolic diseases observed in clinical practice, including Type 2 diabetes mellitus, hypertension and dyslipidemia. The most common term for the metabolic consequences of adiposopathy is currently 'the metabolic syndrome'. Drug usage to treat the metabolic syndrome has focused on the safety and efficacy of treatments directed towards individual components of the metabolic syndrome, and not so much upon adiposopathy itself. However, enough is known about the pathophysiology of adiposopathy to propose diagnostic criteria. Regulatory issues are important obstacles to the research and development of new drug treatments for the metabolic syndrome. It is hoped that these obstacles can, to some extent, be addressed and overcome by clearly defining and increasing our understanding of adiposopathy.
引用
收藏
页码:39 / 59
页数:21
相关论文
共 59 条
[1]   RELATIONSHIPS OF GENERALIZED AND REGIONAL ADIPOSITY TO INSULIN SENSITIVITY IN MEN [J].
ABATE, N ;
GARG, A ;
PESHOCK, RM ;
STRAYGUNDERSEN, J ;
GRUNDY, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :88-98
[2]   Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men [J].
Abate, N ;
Chandalia, M ;
Snell, PG ;
Grundy, SM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2750-2755
[3]   Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM [J].
Abate, N ;
Garg, A ;
Peshock, RM ;
StrayGundersen, J ;
AdamsHuet, B ;
Grundy, SM .
DIABETES, 1996, 45 (12) :1684-1693
[4]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[5]  
2-S
[6]  
Bayes M, 2004, METHOD FIND EXP CLIN, V26, P587
[7]  
Bays H, 2003, EXPERT OPIN PHARMACO, V4, P1901, DOI 10.1517/eoph.4.11.1901.22370
[8]   Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach [J].
Bays, H ;
Mandarino, L ;
DeFronzo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) :463-478
[9]  
Bays H, 2004, EXPERT REV CARDIOVAS, V2, P89
[10]  
Bays H, 2004, CAMBRIDGE MED PUBLIC, P1